DeBoer Mark D, Weber David R, Zemel Babette S, Denburg Michelle R, Herskovitz Rita, Long Jin, Leonard Mary B
Department of Pediatrics (M.D.D.), University of Virginia, Charlottesville, Virginia 22908; Department of Pediatrics (D.R.W.), University of Rochester, Rochester, New York 14642; Department of Pediatrics (B.S.Z., M.R.D., R.H., J.L.), The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104; and Departments of Pediatrics and Medicine (M.B.L.), Stanford University, Stanford, California 94305.
J Clin Endocrinol Metab. 2015 Oct;100(10):3814-21. doi: 10.1210/jc.2015-1637. Epub 2015 Aug 4.
Rapid bone accrual and calcium demands during puberty may result in compensatory increases in PTH and 1,25-dihydroxyvitamin D [1,25(OH)2D] levels; however, these relations have not been established in longitudinal studies.
To determine whether greater bone accrual velocity is associated with greater PTH and 1,25(OH)2D levels in healthy children and adolescents.
Prospective cohort study with baseline PTH, 25-hydroxyvitamin D [25(OH)D], and 1,25(OH)2D levels and dual-energy x-ray absorptiometry whole-body bone mineral content (BMC) accrual over 12 months. Secondary analyses examined bone biomarkers and tibia quantitative computed tomography midshaft cortical-BMC.
A total of 594 healthy participants, ages 5-21 years, with longitudinal measures in a subset of 145 participants.
PTH and 1,25(OH)2D levels.
PTH levels were higher during Tanner stages 3 and 4 compared to Tanner 1 (P < .05) in males and females and were inversely and significantly associated with 25(OH)D levels and dietary calcium intake. In multivariable analyses, greater bone accrual [measured directly as change in dual-energy x-ray absorptiometry-BMC (P < .001) or quantitative computed tomography-BMC (P < .05), or indirectly as growth velocity (P < .05) or greater bone-formation biomarker level (P < .01)] was associated with higher PTH levels, independent of 25(OH)D level and dietary calcium intake. Similar associations were observed between these direct and indirect indices of bone accrual and 1,25(OH)2D levels.
PTH levels rise in midpuberty, in association with multiple measures of bone accrual. This is consistent with compensatory increases in PTH to drive 1,25(OH)2D production and calcium absorption during periods of increased calcium demands. Additional studies are needed to address PTH effects on bone modeling and remodeling during growth and development.
青春期快速的骨量增加和钙需求可能导致甲状旁腺激素(PTH)和1,25 - 二羟维生素D [1,25(OH)₂D]水平的代偿性升高;然而,这些关系尚未在纵向研究中得到证实。
确定在健康儿童和青少年中,更高的骨量增加速度是否与更高的PTH和1,25(OH)₂D水平相关。
前瞻性队列研究,测量基线时的PTH、25 - 羟维生素D [25(OH)D]和1,25(OH)₂D水平,以及12个月内双能X线吸收法测量的全身骨矿物质含量(BMC)增加情况。二次分析检测了骨生物标志物和胫骨定量计算机断层扫描测量的骨干皮质BMC。
共594名5至21岁的健康参与者,其中145名参与者有纵向测量数据。
PTH和1,25(OH)₂D水平。
在男性和女性中,与坦纳1期相比,坦纳3期和4期的PTH水平更高(P < 0.05),且与25(OH)D水平和膳食钙摄入量呈显著负相关。在多变量分析中,更高的骨量增加[直接测量为双能X线吸收法 - BMC的变化(P < 0.001)或定量计算机断层扫描 - BMC的变化(P < 0.05),或间接测量为生长速度(P < 0.05)或更高的骨形成生物标志物水平(P < 0.01)]与更高的PTH水平相关,独立于25(OH)D水平和膳食钙摄入量。在这些直接和间接的骨量增加指标与1,25(OH)₂D水平之间也观察到类似的关联。
青春期中期PTH水平升高,与多种骨量增加指标相关。这与在钙需求增加期间PTH代偿性升高以驱动1,25(OH)₂D生成和钙吸收是一致的。需要进一步研究来探讨PTH在生长发育过程中对骨建模和重塑的影响。